학술논문
531P Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations (mts): Preliminary results of the investigator initiated phase II BEAVER trial
Document Type
Abstract
Author
Source
In Annals of Oncology September 2021 32 Supplement 5:S596-S596
Subject
Language
ISSN
0923-7534